Menu
Recruiting NCT07657286

Inflammatory Cytokines and Oxidative Stress Biomarkers in Diabetic Chronic Kidney Disease Patients

No phase Interventional Chronic Kidney Disease Diabetes

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: aerobic treadmill exercises.
Who it may be relevant to
Registry conditions: Chronic Kidney Disease, Diabetes. Basic parameters: 36 years — 58 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Egypt
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Inflammatory Cytokines and Oxidative Stress Biomarkers Response to Life Style Modification in Diabetic Chronic Kidney Disease Patients

Overview

This research intends to analyze how a 12-week adjustment in lifestyle influences inflammatory cytokines and oxidative stress indicators in overweight individuals diagnosed with type 2 diabetes and moderate CKD

Detailed description

: 60 patients, mostly sedentary, aged 36-58 years, were diagnosed with stages 3 and 4 chronic kidney disease (eGFR 25 to 60 ml/min/1.73 m²) with concomitant type 2 diabetes and indicated body mass indexes (BMI) between 30 to 35 kg/m². The subjects were randomly assigned to two unique groups: Intervention group (Group A): Participants completed supervised aerobic treadmill exercises while sticking to a calorie-limited diet (1200 kcal/day) throughout a 12-week period. Control group (Group B): Participants received standard nephrology care without any alterations in lifestyle. In the initial phases, there was a detailed analysis of biomarkers which was later confirmed in a review conducted at the 12-week mark focusing on TNF-α, IL-6, sCRP, CD, MDA, GSH, GPx, and SOD.

Interventions

  • Other aerobic treadmill exercises
    diet (1200 kcal/day)

Primary outcome measures

  • MDA [Time frame: at baseline and after 12 WEEKS]
  • GSH [Time frame: at baseline and after 12 WEEKS]
  • GPx [Time frame: at baseline and after 12 WEEKS]
  • SOD [Time frame: at baseline and after 12 WEEKS]
  • IL-6 [Time frame: at baseline and after 12 WEEKS]
  • TNF-α [Time frame: at baseline and after 12 WEEKS]
  • CRP [Time frame: at baseline and after 12 WEEKS]
Secondary outcome measures (1)
  • BMI [Time frame: at baseline and after 12 WEEKS]

Eligibility criteria

Inclusion criteria

  • sedentary lifestyle for at least three months prior to enrollment
  • body mass index (BMI) of 30-35 kg/m².

Exclusion criteria

  • using tobacco
  • heart failure
  • coronary arteries
  • severe heart valve problems
  • pregnant
  • liver inflammation
  • kidney transplant
  • physical injuries restricting them from exercising
  • utilization of anti-inflammatory medications

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Single group
Masking
Double blind
Primary purpose
Treatment

Study locations

Egypt · 1 center
  • Mona Mohamed Abdelkhalek — Cairo

Identifiers

NCT: NCT07657286 · diabetic kidney disease

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗